SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013598
Filing Date
2023-08-07
Accepted
2023-08-07 16:16:35
Documents
85
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20230630x10q.htm   iXBRL 10-Q 2401652
2 EX-10.1 cara-20230630xex10d1.htm EX-10.1 705135
3 EX-10.2 cara-20230630xex10d2.htm EX-10.2 13456
4 EX-31.1 cara-20230630xex31d1.htm EX-31.1 12226
5 EX-31.2 cara-20230630xex31d2.htm EX-31.2 12033
6 EX-32.1 cara-20230630xex32d1.htm EX-32.1 10470
7 GRAPHIC cara-20230630xex10d1001.jpg GRAPHIC 83556
  Complete submission text file 0001558370-23-013598.txt   11199935

Data Files

Seq Description Document Type Size
8 EX-101.SCH cara-20230630.xsd EX-101.SCH 63072
9 EX-101.CAL cara-20230630_cal.xml EX-101.CAL 53707
10 EX-101.DEF cara-20230630_def.xml EX-101.DEF 327604
11 EX-101.LAB cara-20230630_lab.xml EX-101.LAB 508218
12 EX-101.PRE cara-20230630_pre.xml EX-101.PRE 467080
79 EXTRACTED XBRL INSTANCE DOCUMENT cara-20230630x10q_htm.xml XML 2001845
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 231147844
SIC: 2834 Pharmaceutical Preparations